Dr Agarwals Eye Hospital peers

Companies like Dr Agarwals Eye Hospitallatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

DRAGARWQ₹5,299.50

Dr Agarwals Eye Hospital Limited

· Pharma & Health
₹ CrorePeersKMCSHILKOVAILOTUSEYEGPTHEALTHGKSLSHALBYINDRAMEDCOARTEMISMEDMcap ₹2,527 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
DRAGARWQ
FY26
KMCSHIL
FY24
KOVAI
FY20
LOTUSEYE
FY26
Peer
Average
Valuation — at last close
P/E◆ 36.05×80.30×68.21×2750.00×966.17× -96%
P/B7.30×—14.97×◆ 3.80×9.39× -22%
EV/EBITDA◆ 17.29×—40.93×69.87×55.40× -69%
Market Cap₹2,527 Cr₹2,439 Cr₹6,452 Cr₹229 Cr₹3,040 Cr -17%
Growth
Revenue CAGR 3Y◆ 20.68%19.96%—4.52%12.24% +69%
Revenue CAGR 5Y◆ 22.59%——10.66%10.66% +112%
Net Income CAGR 3Y23.83%◆ 33.46%—-72.98%-19.76% +221%
Revenue YoY (latest Q)———26.19%26.19%
Net Income YoY (latest Q)———12.65%12.65%
Profitability
EBITDA Margin◆ 30.86%26.75%23.61%6.30%18.89% +63%
Net Income Margin14.89%◆ 17.15%13.29%0.15%10.20% +46%
Return on Common Equity◆ 25.22%—21.94%0.13%11.04% +129%
Return on Capital Employed◆ 16.87%—10.47%-0.54%4.96% +240%
Return on Assets◆ 10.16%—8.54%0.11%4.32% +135%
Credit & Quality
Total Debt/Equity0.24×—1.18×◆ 0.19×0.68× -65%
Interest Coverage8.39×◆ 32.79×7.93×-0.43×13.43× -38%
Scale — latest FY
Revenue / Total Income₹471 Cr₹177 Cr₹712 Cr₹53.7 Cr₹314 Cr +50%
Net Income₹70.1 Cr₹30.4 Cr₹94.6 Cr₹0.1 Cr₹41.7 Cr +68%
Total Assets₹766 Cr—₹1,107 Cr₹82.6 Cr₹595 Cr +29%
EPS₹147.02₹1.86₹86.44₹0.04₹29.45 +399%
Book Value per Share₹726.29—₹393.91₹28.92₹211.42 +244%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.